insulin aspart-szjj 100 UNT/ML Injectable Solution

RxCUI: 2705733
RxNorm name: insulin aspart-szjj 100 UNT/ML Injectable Solution
Display name: insulin aspart-szjj 100 UNT/ML Injectable Solution
Full name: insulin aspart-szjj 100 UNT/ML Injectable Solution
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:27

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761325	Merilog	insulin aspart-szjj	351(k) Biosimilar	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
MERILOG	INSULIN ASPART-SZJJ	Sanofi-Aventis U.S. LLC	eee07a52-1102-4d48-9782-26061db175ad	2025-10-07	Warnings, Adverse reactions	Exact identifier rxcui: 2705733

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
eee07a52-1102-4d48-9782-26061db175ad	insulin aspart-szjj 100 UNT/ML Injectable Solution	SCD	8	These highlights do not include all the information needed to use MERILOG safely and effectively. See full prescribing information for MERILOG™. MERILOG (insulin aspart-szjj) injection, for subcutaneous use. Initial U.S. Approval: 2025 MERILOG™ (insulin aspart-szjj) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differe	20251007
eee07a52-1102-4d48-9782-26061db175ad	insulin aspart-szjj 100 UNT/ML Injectable Solution	PSN	8	These highlights do not include all the information needed to use MERILOG safely and effectively. See full prescribing information for MERILOG™. MERILOG (insulin aspart-szjj) injection, for subcutaneous use. Initial U.S. Approval: 2025 MERILOG™ (insulin aspart-szjj) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differe	20251007